InvestorsHub Logo
icon url

Inoviorulez

12/31/18 9:18 PM

#32604 RE: tommyterrific #32602

Correct. As I stated there has to be discussions ongoing. You have either GlaxoSmithKline, Gilead which may want a piece of the HIV product. Then you have Pfizer and Merck that will want to get a hold of the patents possibly for CCR5 from Dr. Pestell. Then you also have the potential to license out the genetic testing product as well.